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A B S T R A C T
Purpose: Temporal lobe epilepsy (TLE) with bilateral ictal involvement (bitemporal epilepsy, BTLE) is an
intriguing form of TLE whose characteristics need to be carefully identiﬁed as BTLE patients are not good
surgical candidates. The purpose of this study was to deﬁne the anatomo-electro-clinical features
differentiating BTLE from unilateral TLE (UTLE).
Methods: Forty-eight BTLE patients underwent long-term video-EEG monitoring (VEEG) and experi-
enced seizures with bilateral temporal lobe involvement. Their main electro-clinical (demographics,
interictal and ictal EEG, ictal signs) and neuro-imaging [brain magnetic resonance imaging (MRI)] data
were compared with those of a group of 38 UTLE patients.
Results: In comparison with the UTLE patients, the BTLE cohort was signiﬁcantly older at the time of
epilepsy onset (p = 0.023), more frequently experienced bilateral asynchronous interictal epileptiform
discharges during wakefulness (p = 0.001) and sleep (p < 0.001), bilateral upper limb dystonia
(p = 0.005), and auditory auras (p = 0.027), and less frequently showed a recognisable initial ictal EEG
pattern of focal ﬂattening or low-voltage fast activity (p < 0.001), post-ictal memory of seizures
(p = 0.001), staring (p < 0.001), head deviation (p = 0.004), oro-alimentary automatisms (p = 0.006), and
positive brain MRI (p < 0.001). MRI revealed neoplastic lesions (p = 0.007) or alterations other than
hippocampal sclerosis (p = 0.028) only in the UTLE patients.
Conclusion: The possibility of recognising BTLE patients during pre-surgical evaluation or being able to
suspect bitemporal seizures before VEEG by identifying particular anatomo-electro-clinical patterns is
diagnostically important for epileptologists and can help to prevent possible surgical failures.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Temporal lobe epilepsy (TLE) is the most frequently observed
drug-resistant localisation-related epilepsy, especially in epilepsy
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surgery, it is essential to evaluate the localisation of the epileptogenic
zone (EZ), which can be assessed by collecting a careful history
and undertaking detailed anatomo-electro-clinical investigations
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imaging (MRI) and positron emission tomography (PET) neuro-
imaging data are consistent with a diagnosis of unilateral TLE (UTLE),
he or she can be considered a good candidate for surgery [1,7].
TLE patients showing bilateral temporal lobe involvement
during seizures may not be optimal surgical candidates. The
existence of bitemporal epilepsy (BTLE) is well known and many
studies have considered the possible use of surgical therapeutic
strategies, albeit with conﬂicting results [8–12]. However, BTLE
has not yet been clearly deﬁned and relatively little is known about
the anatomo-electro-clinical data characterising BTLE patients.
Hirsch et al. [13] failed to ﬁnd any signiﬁcant clinical or
neuroradiological differences between BTLE and UTLE patients,
although the former had a less frequent history of febrile seizures
(FS). Schulz et al. [14] found an association between BTLE and the
absence of auras, and it has been recently reported that BTLE is
associated with bilateral lateralising ictal signs [15]. It has also
been found that BTLE patients less frequently show ictal motor
signs than those with UTLE, and experience longer periods of post-
ictal unresponsiveness [16].
On the basis of the assumption that pathophysiological
mechanisms and epileptic networks are different in BTLE and
UTLE, it is possible that the two forms have different anatomo-
electro-clinical features. The aim of this study was to investigate
the electro-clinical and neuro-imaging characteristics of a cohort
of BTLE patients in an attempt to differentiate them from UTLE
patients because the identiﬁcation of an anatomo-electro-clinical
phenotype of BTLE would help clinical epileptologists to recognise
or at least suspect BTLE when evaluating TLE patients, especially in
the case of a pre-surgical assessment.
2. Materials and methods
2.1. Data collection
This multicentre study involved three tertiary referral centres
for epilepsy and epilepsy surgery in Milan, Italy: the Claudio
Munari Epilepsy Surgery Centre of Niguarda Hospital, the Clinical
Epileptology Unit of Carlo Besta Neurological Institute, and the
Epilepsy Centre of San Paolo Hospital. Although belonging to
different hospitals, these centres cooperate in the context of a
multidisciplinary Inter-Hospital Department for Pre-surgical
Epilepsy Evaluation (DDEP).
We retrospectively reviewed the electronic charts of 2152 epi-
lepsy patients admitted to the three centres for pre-surgical
evaluations between January 1995 and March 2013: 1548 under-
went epilepsy surgery, and 48 (2.2%) were identiﬁed as having
drug-resistant BTLE. The control group consisted of 38 consecutive
patients with recorded seizures who underwent surgery because
of refractory UTLE between 2005 and 2011 and had been seizure-
free for at least 24 months.
Each of the patients in the two cohorts had undergone long-
term scalp video-EEG (VEEG) using a digital VEEG recording device
(Nihon-Kohden Neurofax or Micromed System Plus Evolution) and
electrodes placed according to the international 10-20 system. A
total of 223 seizures were recorded in the BTLE group and 86 in the
UTLE group. Four BTLE patients also underwent long-term intra-
cerebral electrode stereo-EEG (SEEG) monitoring (Nihon-Kohden
Neurofax). The patients’ anti-epileptic drug (AED) doses were
usually reduced by at least 50% in order to facilitate the recording
of seizures.
All of the patients underwent high-resolution MRI performed
using a 1.5 T (Siemens Avanto or Philips ACS-NT & Achieva) or 3 T
(Philips Achieva TX) scanner. The MRI protocol included transverse
spin-echo double-echo images of the entire brain, coronal fast spin-
echo T2-weighted and spin-echo FLAIR images, and coronal fastspin-echo inversion recovery T1-weighted images. The transversal
and coronal sections were respectively acquired in parallel with or
perpendicularly to the axis of the hippocampal formation.
BTLE was diagnosed on the basis of two ictal electro-clinical
inclusion criteria: a VEEG and/or SEEG recording of at least one
seizure simultaneously or sequentially involving the two temporal
lobes, without the possibility of lateralising its onset and
subsequent development [deﬁned as a non-lateralisable (NL)
bitemporal seizure], and/or the recording of at least two different
seizures alternately arising from the two temporal lobes [deﬁned
as an independent (IND) bitemporal seizure]. More precisely, a
bitemporal seizure was considered NL in the presence of a
discharge simultaneously involving the two temporal lobes
(‘synchronous’) or spreading from one temporal lobe to the
opposite side and back (‘asynchronous’), or ending on the opposite
side (‘side-switching’) (Figs. 1 and 2A and B).
The BTLE patients were divided into two groups (NL or IND
BTLE) on the basis of a blinded review of each seizure. In the case of
disagreement, or when more than one seizure type was recorded in
the same patient, the main seizure pattern was agreed after a
collegial re-evaluation during which the epileptologists not only
assessed the ictal EEG traces of each patient, but also interictal
activity by visually analysing at least ten 20-second wakeful and
sleeping interictal traces samples.
After distinguishing the BTLE and UTLE patients, we collected
all of their available clinical, neurophysiological and neuro-
imaging data, concentrating on the main historical information,
the results of a neurological examination, ictal semiology, ictal and
interictal EEG ﬁndings, and MRI and, when available, ﬂuorodeox-
yglucose PET (FDG-PET) data.
2.2. Statistical analysis
Contingency table analysis was used to evaluate the associa-
tions between the different types of epilepsy and the nominal or
dichotomous variables, with the independence of the rows and
columns being tested by means of Fisher’s exact test. Age at the
time of epilepsy onset, age at the time of evaluation/surgery,
disease duration and monthly seizure frequency were compared in
the UTLE and two BTLE subgroups using the Kruskal–Wallis test. A
p-value of <0.05 was considered signiﬁcant.
The signiﬁcant variables in the three groups underwent post hoc
analysis using a Bonferroni correction for multiple comparisons,
with a p-value of <0.017 being considered signiﬁcant.
The data were analysed using SPSS software (version 22).
3. Results
3.1. General patient characteristics
A total of 48 BTLE patients were identiﬁed between January
1995 and March 2013; the control group consisted of 38 consecu-
tive seizure-free patients who underwent surgery for UTLE
between 2005 and 2011. Table 1 shows their general character-
istics.
The difference in the proportion of BTLE and UTLE patients with
positive family history of epilepsy (8.3% vs 28.9%) was of borderline
signiﬁcance (p = 0.051). There were no signiﬁcant differences in
personal antecedents or the presence of FS between the two groups
except in the case of central nervous system (CNS) infections,
which were reported in only ﬁve BTLE patients (10.4%) (p = 0.018).
The UTLE patients were younger at the time of epilepsy onset
(p = 0.023).
There were no signiﬁcant between-group differences in terms
of gender distribution, age at the time of evaluation/surgery,
disease duration, monthly seizure frequency, the circadian rhythm
Fig. 1. Ictal EEG activity in non-lateralisable BTLE. Two MRI-negative patients showing a synchronous ictal onset and asynchronous ictal discharge propagation. (A) Diffuse
attenuation can be seen for three seconds from the point marked by the asterisk, followed by bitemporal non-lateralisable (NL) theta-delta rhythmic activity (circle), which
accelerates in the right temporal region after 14 s and ends at the same time in the two temporal rows of electrodes. (B) The arrow indicates the beginning of bitemporal NL
theta-delta rhythmic activity, which accelerates in the right temporal region seven seconds after onset and then in the left temporal region, 20 seconds later, ending about two
seconds before the end of the discharge in the right temporal electrodes. BTLE: bitemporal epilepsy; MRI: magnetic resonance imaging.
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the presence of secondary generalised seizures.
None of the patients in either group had any signiﬁcant
neurological examination abnormality.
3.2. Electro-clinical and neuro-imaging ﬁndings
3.2.1. Interictal EEG ﬁndings
There was no difference in background activity between the
BTLE and UTLE patients, but synchronous (and more often
asynchronous) bilateral interictal theta-delta slow activity (ISA)
(wakefulness, p < 0.001; sleep, p < 0.001), and bilateral interictal
epileptiform discharges (IEDs: i.e. spikes, spike-waves and sharp
waves) (wakefulness, p = 0.001; sleep, p < 0.001), were signiﬁ-
cantly more frequent in the temporal regions of the BTLE patients
(Table 2 and Fig. 3).
3.2.2. Ictal EEG ﬁndings
The BTLE patients showed two different ictal discharge
patterns: 32 (66.7%) NL and 16 (33.3%) IND (Figs. 1 and 2A and B).
3.2.3. Initial ictal EEG pattern
Initial ictal EEG ﬂattening or low-voltage fast activity (LVFA)
was signiﬁcantly more frequently observed in the temporal
regions of the UTLE patients (p < 0.001); the ﬁrst detectable ictal
EEG modiﬁcation in the majority of BTLE patients was rhythmic
delta or theta activity (Fig. 2A, B and E).
3.2.4. Ictal signs
Seizure semiology was signiﬁcantly different between the two
groups: post-ictal memory of seizures (PiMS) (p = 0.001), staring
(p < 0.001), head deviation (HD) (p = 0.004), and oro-alimentary
automatisms (OAs) (p = 0.006) were signiﬁcantly less frequent in
the BTLE patients, and PiMS and HD were much less frequent in theNL than in the IND BTLE subgroup. Furthermore, in the latter, the
HD could be ipsilateral or contralateral to the ictal discharge,
whereas it was ipsilateral in most of the UTLE patients (Tab. 2).
Seizure warning (verbally or by means of pushing a warning
button) was signiﬁcantly more frequent among the IND BTLE than
the NL BTLE or UTLE patients (p = 0.004).
The occurrence of auras (including epigastric auras), loss of
consciousness (LOC) and gestural automatisms was not signiﬁ-
cantly different between the BTLE and UTLE patients. However,
although not statistically signiﬁcant, an epigastric aura was
present in 52.6% of the UTLE and only 29.2% of the BTLE patients,
whereas auditory auras were signiﬁcantly more frequent in the
IND BTLE patients (p = 0.027).
There was no signiﬁcant difference in upper limb dystonia
between the BTLE and UTLE patients, but bilateral dystonia (BD)
was only observed in the NL BTLE subgroup and affected 18.8% of
the patients (p = 0.005). When present, dystonia was unilateral in
the majority of IND BTLE patients (appearing contralaterally to the
ictal discharge in most cases), and in all of the UTLE patients in
whom it was always contralateral to the ictal discharge (Table 2).
The median duration of VEEG was signiﬁcantly longer in the
BTLE than in the UTLE patients, and longer in those with IND BTLE
than in those with NL BTLE (p < 0.001). Furthermore, electro-
clinically different seizures were only recorded in the BTLE group,
and mainly in the patients with IND BTLE (p < 0.001).
3.2.5. Neuro-imaging ﬁndings
Table 2 shows the main MRI ﬁndings, and Fig. 2 details of
individual cases. MRI was positive in only 20/48 BTLE patients
(41.7%), but in 35/38 UTLE patients (92.1%) (p < 0.001), who were
the only patients with alterations other than hippocampal sclerosis
(HS), especially tumours (p = 0.007); bilateral MRI abnormalities
(bilateral HS) were only observed in the BTLE group (in 10.4% of the
patients), but this difference was not statistically signiﬁcant.
Fig. 2. Ictal EEG activity in independent BTLE and UTLE. (A) Right temporal EEG activity changes from the point marked by the asterisk, with low-amplitude delta activity
evolving into rhythmic theta activity in the same region. (B) Another seizure in the same patient showing initial low-amplitude theta activity in the left temporal region
(circle) that evolves into rhythmic delta activity in the same region. (C) Coronal FLAIR MRI recording of the same patient showing left HS; (D) Coronal FLAIR MRI recording of a
UTLE patient showing right HS. (E) EEG recording of the same UTLE patient during a seizure showing low-voltage fast ictal activity on the anterior and intermediate temporal
leads (rectangle) that evolves into rhythmic spikes in the same region. BTLE: bitemporal epilepsy; UTLE: unitemporal epilepsy; MRI: magnetic resonance imaging; HS:
hippocampal sclerosis.
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Table 1
General patient characteristics.
NL BTLE IND BTLE Total BTLE UTLE p-value
Gender, M/F 22/10 8/8 30/18 26/12 NS*
Right/left-handed 25/7 14/2 39/9 30/8 NS*
Positive family history of epilepsy, no. of pts (%) 3 (9.4%) 1 (6.3%) 4 (8.3%) 11 (28.9%) p = 0.051*
Antecedents, no. of pts (%) 7 (21.9%) 5 (31.4%) 12 (25.1%) 12 (31.6%) NS*
- Threat of miscarriage 0 (0%) 1 (6.3%) 1 (2.1%) 0 (0%) NS*
- Dystocia 3 (9.4%) 0 (0%) 3 (6.3%) 3 (7.9%) NS*
- Perinatal asphyxia 1 (3.1%) 0 (0%) 1 (2.1%) 6 (15.8%) NS*
- CNS infections 2 (6.3%) 3 (18.8%) 5 (10.4%) 0 (0%) p = 0.018*
- Head trauma 1 (3.1%) 1 (6.3%) 2 (4.2%) 3 (7.9%) NS*
Febrile seizures, no. of pts (%) 9 (28.1%) 4 (25%) 13 (27.1%) 9 (23.7%) NS*
Median age at seizure onset, years (IQR) 15 (8–28) 10 (8–20) 12.5 (8–24.5) 7.5 (2–17) p = 0.023#
Median age at evaluation (BTLE) or surgery (UTLE), years (IQR) 36 (30–47.5) 30 (23–40) 34 (28–46.5) 32 (19–43) NS#
Median disease duration, years (IQR) 17 (10–25) 16.5 (7–24.5) 16.5 (9.5–24.5) 22 (11–31) NS#
Median monthly seizure frequency, No. (IQR) 5 (2.5–8) 4 (2–15) 4.5 (2–9.5) 5 (3–25) NS#
Circadian rhythm of seizures, No. of pts (%) NS*
- Awake 31 (96.9%) 13 (81.3%) 44 (91.7%) 37 (97.4%)
- Only asleep or both awake/asleep 1 (3.1%) 3 (18.8%) 4 (8.3%) 1 (2.6%)
>1 year seizure-free periods, no. of pts (%) 6 (18.8%) 2 (12.5%) 8 (16.7%) 12 (31.6%) NS*
Secondary generalisations, no. of pts (%) 16 (50%) 12 (75%) 28 (58.3%) 23 (60.5%) NS*
NL BTLE: non-lateralisable bitemporal lobe epilepsy; IND BTLE: independent bitemporal lobe epilepsy; UTLE: unitemporal lobe epilepsy; NS: non-signiﬁcant; CNS: central
nervous system; IQR: interquartile range.
* Fisher’s exact test.
# Kruskal–Wallis test.
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and revealed normal brain metabolism in ﬁve, unilateral temporal
hypometabolism in nine, and bilateral temporal hypometabolism
in one; these results often disagreed with the MRI ﬁndings.Table 2
Electro-clinical and neuro-imaging ﬁndings.
NL BTLE I
Days of VEEG, median (IQR) 5 (4–8) 8
Number of recorded seizures per day of VEEG,
median (IQR)
0.60 (0.31–1) 0
Background activity asymmetry, no. (%) 10 (31.3%) 2
Asynchronous bilateral ISA in W, no. (%) 16 (50%) 5
Asynchronous bilateral ISA in S, no. (%) 20 (62.5%) 6
Asynchronous bilateral IEDs in W, no. (%) 12 (37.5%) 5
Asynchronous bilateral IEDs in S, no. (%) 25 (78.1%) 1
Ictal EEG ﬂattening/LVFA, no. (%) 8 (25%) 3
Presence of aura, no. (%) 17 (53.1%) 1
Epigastric aura, no. (%) 8 (25%) 6
Auditory aura, no. (%) 2 (6.3%) 4
Warning of seizure (verbal/push button), no. (%) 7 (21.9%) 1
Post-ictal memory of seizures, no. (%) 9 (28.1%) 1
Loss of consciousness, no. (%) 30 (93.8%) 1
Staring, no. (%) 8 (25%) 2
Upper limb dystonia, no.(%)
- Unilateral
- Bilateral
- Variable
14 (43.8%)
8 (25%)
6 (18.8%)
0 (0%)
7
6
0
1
Head deviation, no. (%)
- Homolateral
- Contralateral
- Variable
11 (34.4%)
N.A.
N.A.
N.A.
1
3
5
2
Oro-alimentary automatisms, no. (%) 23 (71.9%) 9
Gestural automatisms, no. (%) 28 (87.5%) 1
Electro-clinically different recorded seizures, no. (%) 6 (18.8%) 1
Positive brain MRI, no. (%) 13 (40.6%) 7
Bilateral positive brain MRI (HS), no. (%) 3 (9.4%) 2
Main brain MRI ﬁndings, no. (%)
HS 12 (37.6%) 7
Tumours 0 (0%) 0
Others (possible FCD, scars) 1 (3.1%) 0
NL BTLE: non-lateralisable bitemporal lobe epilepsy; IND BTLE IND: independent bitemp
video-EEG monitoring; IQR: interquartile range; NS: non-signiﬁcant; ISA: interictal slow
low-voltage fast activity; MRI: magnetic resonance imaging; HS: hippocampal sclerosi
* Fisher’s exact test.
# Kruskal–Wallis test.
§ Fisher’s exact test: p-value refers to presence/absence of head deviation, without s3.2.6. Invasive recordings
Four of the 48 BTLE patients underwent bitemporal SEEG. IND
bitemporal seizures were recorded in three, in one of whom
they were also synchronous; the fourth patient experienced side-ND BTLE Total BTLE UTLE p-value
 (4–10) 5 (4–9) 3.5 (2–5) p < 0.001#
.45 (0.29–0.63) 0.50 (0.30–1) 0.45 (0.33–1) NS#
 (12.5%) 12 (25%) 10 (26.3%) NS*
 (31.3%) 21 (43.8%) 1 (2.6%) p < 0.001*
 (37.5%) 26 (54.2%) 0 (0%) p < 0.001*
 (31.3%) 17 (35.4%) 2 (5.3%) p = 0.001*
0 (62.5%) 35 (72.9%) 2 (5.3%) p < 0.001*
 (18.8%) 11 (22.9%) 27 (71.1%) p < 0.001*
3 (81.3%) 30 (62.5%) 27 (71.1%) NS*
 (37.5%) 14 (29.2%) 20 (52.6%) NS*
 (25%) 6 (12.5%) 1 (2.6%) p = 0.027*
1 (68.8%) 18 (37.5%) 10 (26.3%) p = 0.004*
2 (75%) 21 (43.7%) 26 (68.4%) p = 0.001*
1 (73.3%) 41 (87.2%) 33 (86.8%) NS*
 (12.5%) 10 (20.8%) 26 (68.4%) p < 0.001*
 (43.8%)
 (37.5%)
 (0%)
 (6.3%)
21 (43.8%)
14 (29.2%)
6 (12.5%)
1 (2.1%)
19 (50%)
19 (50%)
0 (0%)
0 (0%)
NS*
NS*
p = 0.005*
NS*
0 (62.5%)
 (18.8%)
 (31.3%)
 (12.5%)
21 (43.8%) 28 (73.7%)
19 (50%)
9 (23.7%)
0 (0%)
p = 0.004*,§
 (56.3%) 32 (66.7%) 35 (92.1%) p = 0.006*
3 (81.3%) 41 (85.4%) 33 (86.8%) NS*
6 (100%) 22 (45.8%) 0 (0%) p < 0.001*
 (43.8%) 20 (41.7%) 35 (92.1%) p < 0.001*
 (12.5%) 5 (10.4%) 0 (0%) NS*
 (43.8%) 19 (39.6%) 20 (52.6%) NS*
 (0%) 0 (0%) 7 (18.4%) p = 0.007*
 (0%) 1 (2.1%) 8 (21.1%) p = 0.028*
oral lobe epilepsy; UTLE: unitemporal lobe epilepsy; VEEG: long-term non-invasive
 activity; W: wakefulness; S: sleep; IEDs: interictal epileptiform discharges; LVFA:
s; FCD: focal cortical dysplasia.
ub-categorisation for side.
Fig. 3. Interictal EEG in BTLE. Asynchronous bilateral interictal epileptiform discharges in the temporal regions during wakefulness (A) and sleep (B) in a patient with non-
lateralisable BTLE. BTLE: bitemporal epilepsy.
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scalp VEEG. None of the four patients underwent surgery.
3.3. Treatments and outcomes
At the time of evaluation, all of the BTLE patients were receiving
pharmacological treatment (many with two or more AEDs) and
were considered drug resistant [17].
Only four of the 48 BTLE patients underwent surgery (a right
antero-mesial temporal resection). In three cases, pre-surgical
VEEG showed that the ictal discharge started in the right temporal
lobe, but later also strongly involved the left temporal lobe; they
were therefore retrospectively classiﬁed as having NL BTLE. MRI
revealed right HS in one case, but nothing of note in the other two.
In the fourth case, pre-surgical VEEG revealed only right temporal
lobe seizures, but contralateral independent seizures were
recorded after surgery. MRI was negative.
Histopathology revealed type IIIa focal cortical dysplasia (FCD)
in one case, and type I FCD in another; the ﬁndings were
unremarkable in the remaining two cases.
All of the surgically treated BTLE patients had an unsatisfactory
seizure outcome (Engel Class III).
4. Discussion
Despite limitations due to its retrospective nature, this study
allowed the identiﬁcation of an anatomo-electro-clinical pattern
that was peculiar to BTLE and distinct from UTLE. In comparison
with UTLE patients, the patients with BTLE were older at the time
of epilepsy onset, more frequently had auditory auras and bilateral
asynchronous interictal abnormalities (particularly during sleep),
and less frequently had recognisable initial ictal EEG activity (focal
LVFA or ﬂattening), the post-ictal memory of seizures or positive
MRI ﬁndings, and less frequently showed staring, head deviation or
oro-alimentary automatisms. They were also the only patients
with bilateral dystonia and bilateral MRI abnormalities (HS).
Most of our results are considerably different from those of
previous studies, which found that BTLE patients were less likely to
have a history of FS, auras, unitemporal IEDs, ictal motor signs or
lateralised mesial temporal MRI pathology, but more likely to show
bilateral lateralising ictal signs and to experience a longer period of
post-ictal unresponsiveness,[9,11,13–16] particularly those with
independent bitemporal seizures.
There were signiﬁcant differences between our BTLE and
UTLE cohorts in terms of both ictal and interictal EEG activity. Our
BTLE patients showed more frequent bilateral asynchronous
interictal abnormalities during wakefulness and sleeping, which
may be a marker of bilateral temporal lobe involvement in the
epileptic network (Fig. 3). These abnormalities (especially bilateralasynchronous IEDs) have been previously reported in other studies
of BTLE,[11,18] but have also been described in some UTLE
patients,[19] in whom their signiﬁcance for post-surgical out-
comes has not yet been clariﬁed [9,18,20,21]. Consequently, they
cannot be considered sufﬁcient to distinguish the two groups of
patients.
Another important difference is the fact that the BTLE patients
had a less recognisable initial ictal EEG discharge: i.e. focal
ﬂattening or LVFA preceding a rhythmic ictal discharge (Fig. 2). To
the best of our knowledge, this has never been reported before, and
is probably an expression of a scarcely lateralised epileptic
network in BTLE or a very localised discharge in both mesial
structures. This plausibly causes a poorly regionalised change in
brain electrical activity during seizures and the consequent
absence of the early ictal scalp EEG focal signs characterising
UTLE patients [22].
Our BTLE patients showed two different forms of ictal discharge
onset and development, which led us to divide them into those
with NL BTLE (66.7%) and those with IND BTLE (33.3%): other
authors have also adopted a similar sub-categorisation
[9,11,14,18,23]. The fact that AEDs were reduced or withdrawn
in order to facilitate seizure recording should not have had any
causal inﬂuence on the ictal pattern because the same protocol was
used for BTLE and UTLE patients, and previous studies have
excluded the possibility that reduced AED intake leads to
misleading changes in seizure lateralisation or electrical ictal
onset during VEEG [24–27]. We therefore believe that such a sub-
categorisation is a reliable and useful means of describing BTLE.
The two BTLE subgroups were signiﬁcantly different from each
other, as well as signiﬁcantly different from the UTLE group,
particularly in relation to some important ictal signs. The patients
with NL BTLE recalled their seizures post-ictally and showed ictal
HD more rarely than those with IND BTLE or UTLE, and were the
only ones to show BD: taken together, these signs indicate
probable bilateral temporal lobe ictal involvement. There is both
direct and indirect evidence showing that post-ictal memory (and
therefore post-ictal recall of an aura and/or seizure) can be
impaired if a bitemporal seizure has induced transient bilateral
hippocampal dysfunction [28–30]. The absence of clear-cut
interlobar electrical asymmetry during NL bitemporal seizures
may lead to more infrequent HD and the presence of BD. It is well
known that unilateral dystonia is an important lateralising ictal
sign in TLE [31,32], and we found that it was contralateral to ictal
onset in all our UTLE patients and most of the IND BTLE patients
presenting it.
Apart from the fact that electro-clinically different seizures
were only recorded in our IND BTLE patients (a probable reason for
their more frequent warnings of seizures because ictal semiology
may also differ in terms of the duration of an aura before LOC), we
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characterising this subgroup, which can resemble the group of
UTLE patients. Nevertheless, the two BTLE sub-groups had some
common anatomo-electro-clinical characteristics that differenti-
ated them as a whole from the UTLE patients, in addition to the
interictal and initial ictal EEG patterns discussed above.
Unlike Schulz et al. [14], who found that the absence of an aura
was characteristic of BTLE, we did not ﬁnd any signiﬁcant
differences between our BTLE and UTLE patients in terms of the
presence or absence of an aura (including epigastric auras),
although the former more frequently reported auditory auras.
Taken together with the less frequent presence of staring and OAs,
this previously unreported ﬁnding suggests that BTLE patients may
have different brain networks from those of UTLE patients, possibly
leading to more frequent neocortical than mesial seizure onset and
discharge propagation [33–35].
Some of our ﬁndings may have etiological signiﬁcance. It has
been previously reported that FS and MRI-detected HS differenti-
ate UTLE and BTLE,[13,14] but we found that there was no
difference in their distribution in our groups. However, in
comparison with our UTLE patients, those with BTLE were
characterised by: (1) an infrequent family history of epilepsy;
(2) an older age at epilepsy onset; (3) less frequent positive brain
MRI scans; (4) no MRI-detected brain tumours; (5) bilateral MRI
alterations (HS); and (6) a history of CNS infections (Tables 1 and
2). Except for points 1 and 2, which have never been reported
before, these ﬁndings are in agreement with those of earlier studies
[11,14,36]. Moreover, histopathology showed that only two of our
four surgically treated BTLE patients had FCD, and other studies
have found that the main histological ﬁnding in BTLE is HS [8,37],
and have only infrequently described FCD or other focal lesions. All
of these data indicate that the etiologies commonly observed in
UTLE patients are less probable, or at least differently expressed, in
patients with BTLE, thus leading to a distinct anatomo-electro-
clinical phenotype.
Bitemporal epileptogenicity cannot be attributed to a longer
disease duration or more frequent seizures, as suggested by other
authors [38], because there was no difference in these variables
between our UTLE and BTLE cohorts. Moreover, as HS seems to be
associated with the duration of epilepsy (particularly when FCD is
not detected) [39], the comparable duration of epilepsy in the two
groups may explain the similar incidence of HS.
The VEEG recordings of our BTLE patients (especially those with
IND BTLE) were signiﬁcantly longer than those of our UTLE patients
(Table 2). As there was no signiﬁcant difference in the median
number of recorded seizures per day in the two groups, it is likely
that bitemporal epileptogenicity was suspected on the grounds of
the patients’ histories. However, the fact that the seizures of some
IND BTLE patients may cluster on only one temporal lobe for
months [36] may make even the longest VEEG monitoring period
insufﬁcient to lateralise a patient’s EZ unequivocally. We therefore
suggest that IND BTLE should be considered whenever patients
report ictal signs that are very different from those documented by
VEEG, and that the diagnostic process should be guided by the
patient’s overall clinical history and ictal signs (including those
indicated by anamnestic semiology) and neuro-imaging ﬁndings
whenever VEEG does not exclude it.
We could not include PET data in the statistical analysis because
only some of our patients underwent a PET examination, but we
believe that such data might further contribute to identifying BTLE
patients, particularly in the presence of a negative or bilateral PET
signal alteration. However, this will need to be veriﬁed in a
speciﬁcally designed comparative study.
Previous studies have attempted to identify possible prognostic
factors indicating a favourable surgical outcome in patients
identiﬁed as having BTLE by means of scalp VEEG or invasiverecordings [8,10,40], but their results are partially contradictory
and sometimes based on the percentage reduction in seizure
frequency. Some have indicated good surgical outcomes
[8,10,12,40], but others have found unfavourable outcomes
[9,11,14,41] and even a worsening after surgery [37]. On the basis
of the data relating to our few patients who underwent surgery,
patients with BTLE are not good candidates for resection, and
probably account for a large proportion of poor TLE surgery
outcomes. Other investigators have described the usefulness of
invasive recordings [8,10,40], but we believe that a careful pre-
surgical non-invasive work-up can adequately identify patients
with BTLE and that therapeutic strategies other than resective
surgery should be further investigated for those who are drug
resistant [42,43].
Unlike Hirsch et al. [13], who concluded that BTLE and UTLE are
part of a continuum and share common pathophysiological
mechanisms, and that UTLE could substantially be considered a
bilateral disease, we think that they should be treated as two
distinct entities in the context of TLE spectrum, even if they may
have some similar characteristics. This is strongly supported by
their different anatomo-electro-clinical phenotypes, although it
has to be pointed out that these may not apply to patients with
non-drug-resistant BTLE or UTLE.
Further studies are still required to investigate other possible
different etiologies (channel diseases, genetic causes, SNC infec-
tions, auto-immune pathologies) and characterise the neuropsy-
chological and brain metabolism aspects of the disease.
Furthermore, our retrospectively identiﬁed anatomo-electro-
clinical patterns of BTLE might also need to be veriﬁed in
prospective studies of pre-surgical TLE patients, which could also
provide additional electro-clinical and etiopathogenetic informa-
tion that could lead to new pharmacological or palliative surgical
options. Another possibility is to use VEEG in supposedly UTLE
patients with bad surgical outcome in order to identify the real
origin of the ictal discharges.
5. Conclusions
The ﬁndings of this study provide evidence that BTLE and UTLE
have different characteristics and may belong to separate
symptomatological constellations. They also suggest a particular
anatomo-electro-clinical pattern that allows the non-invasive
recognition of BTLE and could be used in the pre-surgical
evaluation of patients with presumed TLE in order to verify or
exclude the presence of possible BTLE.
Conﬂict of interest
None.
Acknowledgements
We would like to thank Dr. Angelo Del Sole and Dr. Antonio
Scarale (specialists in Nuclear Medicine) for the PET scan
examinations.
We would also like to thank the Paolo Zorzi Association for the
Neurosciences for supporting the Carlo Besta Epilepsy Surgery
Group.
References
[1] Engel J. Surgery for seizures. N Engl J Med 1996;334:647–52.
[2] Semah F, Picot MC, Adam C, Broglin D, Arzimanoglou A, Bazin B, et al. Is the
underlying cause of epilepsy a major prognostic factor for recurrence? Neu-
rology 1998;51:1256–62.
G. Didato et al. / Seizure 31 (2015) 112–119 119[3] Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of
surgery for temporal-lobe epilepsy. N Engl J Med 2001;345:311–8. http://
dx.doi.org/10.1056/NEJM200108023450501.
[4] Engel J, McDermott MP, Wiebe S, Langﬁtt JT, Stern JM, Dewar S, et al. Early
surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial.
JAMA 2012;307:922–30. http://dx.doi.org/10.1001/jama.2012.220.
[5] Kahane P, Landre´ E, Minotti L, Francione S, Ryvlin P. The Bancaud and Talairach
view on the epileptogenic zone: a working hypothesis. Epileptic Disord
2006;8(Suppl. 2):S16–26.
[6] Lu¨ders HO, Najm I, Nair D, Widdess-Walsh P, Bingman W. The epileptogenic
zone: general principles. Epileptic Disord 2006;8(Suppl. 2):S1–9.
[7] Kilpatrick C, O’Brien T, Matkovic Z, Cook M, Kaye A. Preoperative evaluation for
temporal lobe surgery. J Clin Neurosci 2003;10:535–9. http://dx.doi.org/
10.1016/S0967-5868(03)00080-8.
[8] Hirsch LJ, Spencer SS, Spencer DD, Williamson PD, Mattson RH. Temporal
lobectomy in patients with bitemporal epilepsy deﬁned by depth electroen-
cephalography. Ann Neurol 1991;30:347–56. http://dx.doi.org/10.1002/
ana.410300306.
[9] Schulz R, Lu¨ders HO, Hoppe M, Tuxhorn I, May T, Ebner a. Interictal EEG and
ictal scalp EEG propagation are highly predictive of surgical outcome in mesial
temporal lobe epilepsy. Epilepsia 2000;41:564–70.
[10] Holmes MD, Miles AN, Dodrill CB, Ojemann Ga, Wilensky AJ. Identifying
potential surgical candidates in patients with evidence of bitemporal epilepsy.
Epilepsia 2003;44:1075–9.
[11] Okujava M, Schulz R, Hoppe M, Ebner a, Jokeit H, Woermann FG. Bilateral
mesial temporal lobe epilepsy: comparison of scalp EEG and hippocampal
MRI-T2 relaxometry. Acta Neurol Scand 2004;110:148–53. http://dx.doi.org/
10.1111/j.1600-0404.2004.00305.x.
[12] Aghakhani Y, Liu X, Jette N, Wiebe S. Epilepsy surgery in patients with bilateral
temporal lobe seizures: A systematic review. Epilepsia 2014;1:10. http://
dx.doi.org/10.1111/epi.12856.
[13] Hirsch LJ, Spencer SS, Williamson PD, Spencer DD, Mattson RH. Comparison of
bitemporal and unitemporal epilepsy deﬁned by depth electroencephalogra-
phy. Ann Neurol 1991;30:340–6. http://dx.doi.org/10.1002/ana.410300305.
[14] Schulz R, Lu¨ders HO, Hoppe M, Jokeit H, Moch a, Tuxhorn I, et al. Lack of aura
experience correlates with bitemporal dysfunction in mesial temporal lobe
epilepsy. Epilepsy Res 2001;43:201–10.
[15] Loesch AM, Feddersen B, Irsel Tezer F, Hartl E, Re´mi J, Vollmar C, et al. Seizure
semiology identiﬁes patients with bilateral temporal lobe epilepsy. Epilepsy
Res 2015;109:197–202. http://dx.doi.org/10.1016/j.eplepsyres.2014.11.002.
[16] Rehulka P, Dolezˇalova´ I, Janousˇova´ E, Toma´sˇek M, Marusicˇ P, Bra´zdil M, et al.
Ictal and postictal semiology in patients  with bilateral temporal lobe
epilepsy. Epilepsy Behav 2014;41:40–6. http://dx.doi.org/10.1016/j.yebeh.
2014.09.033.
[17] Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al.
Deﬁnition of drug resistant epilepsy: consensus proposal by the ad hoc Task
Force of the ILAE Commission on Therapeutic Strategies. Epilepsia
2010;51:1069-77. http://dx.doi.org/10.1111/j. 1528-1167.2009.02397.x.
[18] Steinhoff BJ, So NK, Lim S, Lu¨ders HO. Ictal scalp EEG in temporal lobe epilepsy
with unitemporal versus bitemporal interictal epileptiform discharges. Neu-
rology 1995;45:889–96.
[19] Ergene E, Shih JJ, Blum DE,So NK. Frequency of bitemporal independent interictal
epileptiform discharges in temporal lobe epilepsy. Epilepsia 2000;41:213–8.
[20] Malow Ba, Selwa LM, Ross D, Aldrich MS. Lateralizing value of interictal spikes
on overnight sleep-EEG studies in temporal lobe epilepsy. Epilepsia
1999;40:1587–92.
[21] Janszky J, Ra´sonyi G, Clemens Z, Schulz R, Hoppe M, Barsi P. Clinical differences
in patients with unilateral hippocampal sclerosis and unitemporal or bitem-
poral epileptiform discharges. Seizure 2003;1311:550–4. http://dx.doi.org/
10.1016/S1059.
[22] Pelliccia V, Mai R, Francione S, Gozzo F, Sartori I, Nobili L, et al. Ictal EEG
modiﬁcations in temporal lobe epilepsy. Epileptic Disord 2013;15:392–9.
http://dx.doi.org/10.1684/epd.2013.0615.[23] Joo EY, Lee EK, Tae WS, Hong SB. Unitemporal vs bitemporal hypometabolism
in mesial temporal lobe epilepsy. Arch Neurol 2004;61:1074–8. http://
dx.doi.org/10.1001/archneur.61.7.1074.
[24] Spencer SS, Spencer DD, Williamson PD, Mattson RH. Ictal effects of anticonvul-
sant medication withdrawal in epileptic patients. Epilepsia 1981;22:297–307.
[25] Marciani MG, Gotman J. Effects of drug withdrawal on location of seizure
onset. Epilepsia 1986;27:423–31.
[26] So N, Gotman J. Changes in seizure activity following anticonvulsant drug
withdrawal. Neurology 1990;40:407–13.
[27] Yen DJ, Chen C, Shih YH, Guo YC, Liu LT, Yu HY, et al. Antiepileptic drug
withdrawal in patients with temporal lobe epilepsy undergoing presurgical
video-EEG monitoring. Epilepsia 2001;42:251–5.
[28] Helmstaedter C, Elger CE, Lendt M. Postictal courses of cognitive deﬁcits in
focal epilepsies. Epilepsia 1994;35:1073–8.
[29] Schulz R, Lu¨ders HO, Noachtar S, May T, Sakamoto A, Holthausen H, et al.
Amnesia of the epileptic aura. Neurology 1995;45:231–5.
[30] Gallassi R. Epileptic amnesic syndrome: an update and further considerations.
Epilepsia 2006;47(Suppl. 2):103–5. http://dx.doi.org/10.1111/j.1528-1167.
2006.00704.x.
[31] Kotagal P, Lu¨ders H, Morris HH, Dinner DS, Wyllie E, Godoy J, et al. Dystonic
posturing in complex partial seizures of temporal lobe onset: a new lateraliz-
ing sign. Neurology 1989;39:196–201.
[32] Bleasel A, Kotagal P, Kankirawatana P, Rybicki L. Lateralizing value and
semiology of ictal limb posturing and version in temporal lobe and extra-
temporal epilepsy. Epilepsia 1997;38:168–74.
[33] Maldonado HM, Delgado-Escueta AV, Walsh GO, Swartz BE, Rand RW. Com-
plex partial seizures of hippocampal and amygdalar origin. Epilepsia
1988;29:420–33.
[34] Henkel A, Noachtar S, Pfa¨nder M, Lu¨ders HO. The localizing value of the
abdominal aura and its evolution: a study in focal epilepsies. Neurology
2002;58:271–6.
[35] Maillard L, Vignal J-P, Gavaret M, Guye M, Biraben A, McGonigal A, et al.
Semiologic and electrophysiologic correlations in temporal lobe seizure sub-
types. Epilepsia 2004;45:1590–9. http://dx.doi.org/10.1111/j. 0013-9580.2004.
09704.x.
[36] Spencer D, Gwinn R, Salinsky M, O’Malley JP. Laterality and temporal distri-
bution of seizures in patients with bitemporal independent seizures during a
trial of responsive neurostimulation. Epilepsy Res 2011;93:221–5. http://
dx.doi.org/10.1016/j.eplepsyres.2010.12.010.
[37] Yang K, Su J, Lang Y, Liu S-P, Yin J. Contradictory imaging and EEG results in
resection surgery of bitemporal lobe epilepsy: A case report. Exp Ther Med
2014;7:731–3. http://dx.doi.org/10.3892/etm.2013.1462.
[38] Niediek T, Franke HG, Degen R, Ettlinger G. The development of independent
foci in epileptic patients. Arch Neurol 1990;47:406–11.
[39] Tassi L, Meroni A, Deleo F, Villani F, Mai R, Russo G, Lo. et al. Temporal lobe
epilepsy: neuropathological and clinical correlations in 243 surgically treated
patients. Epileptic Disord 2009;11:281–92. http://dx.doi.org/10.1684/epd.
2009.0279.
[40] Boling W, Aghakhani Y, Andermann F, Sziklas V, Olivier a. Surgical treatment of
independent bitemporal lobe epilepsy deﬁned by invasive recordings. J Neurol
Neurosurg Psychiatry 2009;80:533–8. http://dx.doi.org/10.1136/jnnp.2008.
155291.
[41] Spanedda F, Cendes F, Gotman J. Relations between EEG seizure morphology,
interhemispheric spread, and mesial temporal atrophy in bitemporal epilepsy.
Epilepsia 1997;38:1300–14.
[42] McLachlan RS, Pigott S, Tellez-Zenteno JF, Wiebe S, Parrent A. Bilateral hippo-
campal stimulation for intractable temporal lobe epilepsy: impact on seizures
and memory. Epilepsia 2010;51:304–7. http://dx.doi.org/10.1111/j.1528-1167.
2009.02332.x.
[43] Luo H, Zhao Q, Tian Z, Wu Z, Wang F, Lin H, et al. Bilateral stereotactic
radiofrequency amygdalohippocampectomy for a patient with bilateral tem-
poral lobe epilepsy. Epilepsia 2013;54:e155–8. http://dx.doi.org/10.1111/
epi.12387.
